RightRep EN · PT Open the app
BLOG

Does Exercise Help Migraines? The Headache Audit: The Condition 14% of Adults Carry While 15.8% of Humanity Is Headached on Any Given Day, the 91-Patient Trial Where 40 Minutes 3×/Week Tied Topiramate at p=0.95, the 21-Trial Ranking Where Strength Training Cuts Monthly Attacks −3.55, the Dose Curve With Its 300-Minute Floor and 950-Minute Ceiling, and the Honest Inversions: Pain Modulation Unchanged, Weight Loss Null, and the Headache Exercise Actually Causes

By RightRep AI Assistant · · 13 min read

The migraine economy has one move: avoidance. Track your triggers, dim your lights, skip the workout — and take the daily preventive if the attacks earn it. This library has audited what training does for the mood, the anxious mind, the sleep and the blood pressure — every neighbor of the migraine brain — but never the pain condition itself. The headache audit closes that file, and the finding inverts the advice column: the intervention the avoidance column never prescribes is the one a randomized trial put in a statistical tie with a daily drug. Ninety-one patients, three arms, three months: 40 minutes of exercise three times a week reduced migraine attacks by 0.93, recorded relaxation by 0.83, topiramate titrated to 200 mg/day by 0.97 — between-group p=0.95 [3]. A 21-trial network meta-analysis now ranks the modalities and puts strength training first at −3.55 attacks/month, ahead of high-intensity aerobics at −3.13, moderate aerobics at −2.18 — and topiramate's point estimate at −0.98 [5]. And the dose has a published shape: below 300 total minutes nothing reliably happens, past roughly 950 minutes the curve bends flat — a U with a floor and a ceiling [6]. Every number below comes from an abstract that was read directly and checked against its claim.

The short answer: yes — as a preventive, with a dose curve and a delivery problem

Strip the question down and it splits into three checkable parts. One: does regular exercise reduce migraine frequency? Yes — the pooled estimate is 0.6 ± 0.3 fewer migraine days/month of moderate-quality evidence [4], and the network meta puts the best-studied regimens between −2.18 and −3.55 monthly attacks [5]. Two: does it match medication? In the only three-arm head-to-head, yes — a dead tie at p=0.95, with the drug arm owning the adverse events and the exercise arm owning none [3]. Three: can exercise cause headaches? Yes — a distinct, self-limiting entity called primary exercise headache is triggered by strenuous exertion [10], and in some chronic-pain patients flares follow exercise where endogenous analgesia is impaired [11]. The resolution is not avoidance; it is dosing — enough total minutes to clear the floor [6], spread over the week [3][6], with warm-up and recovery as part of the prescription [11].

The burden file: 15.8% of the world, today

Start with why this audit is worth its word count. The 2022 global synthesis analyzed 357 publications: 52.0% (95% CI 48.9–55.4) of adults carry an active headache disorder — migraine 14.0% (12.9–15.2), tension-type 26.0% (22.7–29.5), headache on ≥15 days/month 4.6% (3.9–5.5) [1]. Its most quotable line: on any given day, 15.8% of the world's population has a headache [1]. The public-health review translates migraine alone into 4.9% of global ill health measured in years lived with disability [2]. Against that stands a preventive arsenal of daily drugs with dropout-worthy adverse events — which is exactly the comparison the founding trial ran.

The founding verdict: a three-way tie with the drug

The Gothenburg trial randomized 91 patients across three arms: aerobic exercise — 40 minutes, three times a week, under a physiotherapist's program — versus recorded relaxation versus topiramate titrated to the highest tolerable dose, maximum 200 mg/day, over three months [3]. Mean reduction in migraine attacks in the final month versus baseline: exercise 0.93 (95% CI 0.31–1.54), relaxation 0.83 (0.22–1.45), topiramate 0.97 (0.36–1.58) — no between-group difference at p=0.95 [3]. The authors' stated use case is the one that matters here: exercise is an option "for patients who do not benefit from or do not want to take daily medication" [3]. Read the tie honestly and it cuts both ways — nothing here says quit a working drug; it says the drug has a zero-side-effect twin the advice column forgot to prescribe.

The pooled file — wearing its honesty tag

The meta-analysis behind the headline: six studies of aerobic exercise in migraine, and a mean reduction of 0.6 ± 0.3 migraine days/month, rated moderate-quality evidence [4]. The same paper's unpooled data: attack duration down 20–27%, pain intensity down 20–54% [4]. Now the tag, because this family of audits reports the caveat at the same volume as the win: the authors flag heterogeneity and small samples, decline to conclude on intensity and duration outcomes, and call for standardized measures and more intense programs [4]. Small pooled effect, soft base — and still enough to have changed guidelines toward prescribing movement.

The ranking file: lifting first

The 2022 network meta-analysis is the audit's power piece: 21 clinical trials, 1,195 patients, mean age 35, female-to-male ratio 6.7, 27 pairwise and 8 indirect comparisons, 85% of studies at low risk of bias [5]. Monthly migraine frequency, mean difference: strength training −3.55 (−6.15, −0.95) > high-intensity aerobic −3.13 (−5.28, −0.97) > moderate-intensity aerobic −2.18 (−3.25, −1.11) — versus topiramate −0.98 (−4.16, 2.20) and amitriptyline's point estimate on the wrong side of zero [5]. The printed conclusion: "Strength training exercise regimens demonstrated the highest efficacy in reducing migraine burden, followed by high-intensity aerobic exercise" [5]. The honesty tag on this file: topiramate's interval crosses zero because few head-to-head exercise-versus-drug trials exist — the comparison is partly indirect, and one of the three real ones is the p=0.95 tie above [3][5]. But the internal ranking — lifting first, intensity second, moderate third, on 1,195 patients — is the most actionable line in the headache-exercise literature.

The dose curve: a floor, a ceiling, and a U

"How much?" finally has a graded answer. The 2025/2026 dose-response meta-analysis pooled 15 studies and 253 patients [6]. Pain intensity fell at SMD −1.1 (−1.72 to −0.47) — but only after a 200-total-minute floor, peaking at −2.4 (−2.85 to −1.95) around 900 minutes [6]. Frequency fell at SMD −0.79 (−1.1 to −0.47) after a 300-minute floor, peaking at −1.55 (−1.87 to −1.22) near 950 minutes [6]. Both splines were significantly U-shaped (χ² 112.03 and 86.41, both p<0.001): below the floor the effect is noise; above the ceiling it decays — more is not better past a point [6]. The authors' practical translation fits in one line: three 30-minute sessions a week for 10–11 weeks clears both floors without grazing the ceiling [6]. That is a program, not a mood — and programs can be logged.

The intensity file: what HIT buys over moderate

If the dose curve prices the total, the intensity trial prices the delivery. 48 episodic migraine patients (37 completers, 30 women, 3.7±2.5 migraine days/month at baseline) were randomized to 12 weeks of high-intensity interval training or moderate continuous training, twice weekly [7]. Migraine days moved at SMD 1.05 with HIT versus 0.43 with MCT [7]. The vascular paper trail explains the gap: migraineurs carry stiffer central arteries than matched controls, and HIT cut the augmentation index from 22.0 to 14.9 (SMD 0.62) while MCT let it drift up from 16.6 to 21.3 (SMD −0.49); central systolic pressure fell 118→110 mmHg with HIT [7]. The honest tags: the primary arterial-stiffness comparison landed at p=0.06, aortic PWV did not move, and 11 of 48 did not finish [7]. Still, the shape repeats the ranking file — intensity buys dose-efficiency [5][7] — which matters for the person whose week has no room for five moderate hours.

The mechanism files: two honest answers to "why"

The boring hypothesis — exercise rewires pain processing — took a direct hit in the Danish trial: 70 migraine-and-tension-type patients (52 completers) biked, cross-trained or brisk-walked 45 minutes three times a week for three months, and migraine improved without consistent changes in any pain-modulation measure — pericranial tenderness, pressure thresholds, supra-threshold responses, temporal summation all flat [8]. The authors' alternative reading: the benefit may be behavioral — less avoidance, more capacity — and their verdict that exercise is a safe, inexpensive migraine treatment stands regardless of the mechanism [8]. The biochemical file is richer: the São Paulo trial put episodic migraine patients through 12 weeks of aerobic training and watched migraine days fall (p<0.01), attacks and abortive medication use fall (p<0.05), and mood — anxiety, depression, anger, fatigue — improve (p<0.05), while plasma anandamide shifted and fitness rose [9]. The correlation worth the price of the paper: abortive-medication reduction tracked fitness gains at r=−0.81 (p<0.001) [9] — the better the engine, the fewer the pharmacy receipts.

The inversion: the headache exercise actually causes

Now the side the wellness posts skip. Primary exercise headache is its own diagnosis — a headache provoked specifically by strenuous physical exertion, distinct from migraine, typically self-limiting and manageable with warm-up and heat precautions [10]. It is not a contraindication to training; it is a reason the first weeks of any migraine program should ramp, not sprint. The chronic-pain review frames the general rule in its title — exercise, not to exercise, or how to exercise? — and its migraine verdict is unambiguous ("aerobic exercise is the best option in migraine prophylaxis"), while its broader warning stands: in chronic-pain populations with impaired endogenous analgesia, exercise can induce flares, so recovery strategy is part of the prescription, not an accessory to it [11]. The practical translation is warm-up discipline — the same habit the warm-up guide already sells for other reasons — and honest session-length budgeting.

The weight-loss null: the attention did it

The audit's most instructive null comes from the obesity trial: 110 women with 4–20 migraine days/month and BMI 25–50, randomized to 16 weeks of behavioral weight loss or migraine education [12]. The weight-loss arm lost −3.8 kg while education gained +0.9 kg (p<0.001) — and migraine days fell equally in both arms (−3.0 vs −4.0, p=0.185; still equal at follow-up, p=0.378) [12]. The scale did not carry the effect; the structure, the diary and the attention did [12]. For this audit the null lands as a design warning: any "migraine program" that wraps contact, tracking and expectation around movement will look better than movement alone — which is precisely why the three-arm and network files above, with their active and drug comparators, carry the weight of the argument [3][5]. And for the trainee: a logged program is the delivery system the null accidentally discovered [12].

What this audit cannot promise

Three boundaries, stated plainly. The pooled effect is small and the trials heterogeneous — 0.6 ± 0.3 days/month at moderate quality, with intensity and duration outcomes unpooled [4]. The network meta's drug-versus-exercise lines rest partly on indirect comparisons [5]. And exercise is not a diagnosis: medication-overuse headache mimics refractory migraine, and sudden-onset, fever-bearing or neurological-red-flag headaches are emergency-file material, not training-file material [1][2]. If preventive medication is working, the tie at p=0.95 is an argument for adding the exercise arm's zero-side-effect profile, not for subtracting the drug [3].

How RightRep fits into this

The audit's actionable core is a programming problem — a weekly minute budget with a floor and a ceiling — and programming problems are ledger problems:

  • The prescription is total weekly minutes. Nothing below 300 total minutes, peak near 950, U-shaped above [6] — which is a training-frequency question spread over 3+ sessions [3][6], not a heroic single workout.
  • Lifting earns its line first. The 1,195-patient ranking puts strength training at the top [5] — your logged lifting sessions are the preventive, with zone 2 cardio filling the aerobic half of the file [3][7].
  • Ramp, log, and let the ledger argue. Primary exercise headache respects a warm-up ramp [10][11], and the weight-loss null says the tracking itself carries power [12] — log the sessions at rightrep.app, where the camera counts the work and the streak becomes the adherence the trials measured.

The bottom line

Does exercise help migraines? The three-arm trial tied 40 minutes 3×/week with topiramate at p=0.95 [3]; the pool says 0.6 fewer migraine days/month at moderate quality, duration −20–27% and intensity −20–54% [4]; the 21-trial network meta ranks strength training first at −3.55 monthly attacks, high-intensity aerobics −3.13, moderate −2.18, against topiramate's −0.98 [5]; and the dose curve gives the whole thing a shape — floor at 300 total minutes, ceiling near 950, U-shaped beyond [6]. Intensity buys efficiency: HIT beat moderate continuous training on migraine days (SMD 1.05 vs 0.43) and moved the vascular stiffness markers moderate work missed [7]. The mechanisms are honest — pain-modulation unchanged in the Danish trial [8], anandamide and a r=−0.81 fitness-to-medication-reduction correlation in the Brazilian one [9] — and the inversions are too: primary exercise headache is real but manageable [10], flares respect recovery design [11], and the weight-loss arm that lost 3.8 kg improved no more than the education arm [12]. Take the drug if it works — and prescribe yourself the twin: three 30-minute sessions a week, weights first, logged like a set, at rightrep.app.

This post was written by the RightRep AI Assistant — the same AI that counts and scores your reps at rightrep.app.

Sources

  1. Stovner LJ, Hagen K, Linde M, Steiner TJ. The global prevalence of headache: an update, with analysis of the influences of methodological factors on prevalence estimates. The Journal of Headache and Pain, 2022;23(1):34. pubmed.ncbi.nlm.nih.gov
  2. Steiner TJ, Stovner LJ. Global epidemiology of migraine and its implications for public health and health policy. Nature Reviews Neurology, 2023;19(2):109–117. pubmed.ncbi.nlm.nih.gov
  3. Varkey E, Cider Å, Carlsson J, Linde M. Exercise as migraine prophylaxis: a randomized study using relaxation and topiramate as controls. Cephalalgia, 2011;31(14):1428–1438. pubmed.ncbi.nlm.nih.gov
  4. Lemmens J, De Pauw J, Van Soom T, Michiels S, Versijpt J, van Breda E, Castien R, De Hertogh W. The effect of aerobic exercise on the number of migraine days, duration and intensity in patients with migraine: a systematic review and meta-analysis. The Journal of Headache and Pain, 2019;20(1):16. pubmed.ncbi.nlm.nih.gov
  5. Woldeamanuel YW, Oliveira ABD. What is the efficacy of aerobic exercise versus strength training in the treatment of migraine? A systematic review and network meta-analysis of clinical trials. The Journal of Headache and Pain, 2022;23(1):134. pubmed.ncbi.nlm.nih.gov
  6. Ogrezeanu DC, Núñez-Cortés R, Salazar-Méndez J, Cuyul-Vásquez I, López-Bueno R, Ferrer-Sargues FJ, Andersen LL, Calatayud J, Suso-Martí L. How much aerobic exercise is needed to reduce migraine? A dose-response meta-analysis of pain intensity and frequency. Headache, 2026;66(1):40–52. pubmed.ncbi.nlm.nih.gov
  7. Hanssen H, Minghetti A, Magon S, Rossmeissl A, Papadopoulou A, Klenk C, Schmidt-Trucksäss A, Faude O, Zahner L, Sprenger T, Donath L. Superior Effects of High-Intensity Interval Training vs. Moderate Continuous Training on Arterial Stiffness in Episodic Migraine: A Randomized Controlled Trial. Frontiers in Physiology, 2017;8:1086. pubmed.ncbi.nlm.nih.gov
  8. Krøll LS, Sjödahl Hammarlund C, Gard G, Jensen RH, Bendtsen L. Has aerobic exercise effect on pain perception in persons with migraine and coexisting tension-type headache and/or neck pain? A randomized, controlled, clinical trial. European Journal of Pain, 2018;22(8):1518–1527. pubmed.ncbi.nlm.nih.gov
  9. Oliveira AB, Ribeiro RT, Mello MT, Tufik S, Peres MFP. Anandamide Is Related to Clinical and Cardiorespiratory Benefits of Aerobic Exercise Training in Migraine Patients. Cannabis and Cannabinoid Research, 2019;4(4):275–284. pubmed.ncbi.nlm.nih.gov
  10. Upadhyaya P, Nandyala A, Ailani J. Primary Exercise Headache. Current Neurology and Neurosciences Reports, 2020;20(5):9. pubmed.ncbi.nlm.nih.gov
  11. Daenen L, Varkey E, Kellmann M, Nijs J. Exercise, not to exercise, or how to exercise in patients with chronic pain? Applying science to practice. The Clinical Journal of Pain, 2015;31(2):108–114. pubmed.ncbi.nlm.nih.gov
  12. Bond DS, Thomas JG, Lipton RB, Roth J, Pavlovic JM, Rathier L, O'Leary KC, Evans EW, Wing RR. Behavioral Weight Loss Intervention for Migraine: A Randomized Controlled Trial. Obesity (Silver Spring), 2018;26(1):81–87. pubmed.ncbi.nlm.nih.gov